NKGen Biotech to Present Long-Term Follow-Up of Troculeucel in Moderate Alzheimer’s Disease at CTAD 2026
NKGen Biotech Inc NKGN
$0.01
▲ +0.00%
(+$0.00)
Open
$0.01
Prev Close
$0.01
Day Range
$0.01 – $0.01
52W Range
$0.00 – $0.20
Market Cap
$1.44M
Beta
0.71
EPS (TTM)
$-1.09
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | OTC MARKETS |
| Currency | USD |
| IPO Date | 2021-05-21 |
| Shares Out. | 130,600,000 |
| Website | nkgenbiotech.com/ ↗ |
| Phone | 13026365400 |
NKGen Biotech Inc is a publicly traded company under the ticker symbol NKGN on the OTC MARKETS, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.